Aurobindo gets $23M settlement; Study finds FDA drug shortages data confusing;

> India's Aurobindo Pharma said that it will receive $23.3 million from the former owner of the U.S. neutraceutical company Natrol to settle litigation over financial irregularities found after it bought the business out of bankruptcy. Story

> IPEC-Americas says excipient makers should be achieving a new standard by the third quarter of this year. Report

> Study finds FDA drug shortages data confusing. Report

> Seunghee Kim, a veteran member of South Korea's Ministry of Food and Drug Safety, has been named to become its first female minister. Report

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.